AML1 and the AML1-ETO fusion protein in the pathoge... [Oncogene. 2001] - PubMed

Save items

loading

Related citations in PubMed

The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. [Blood. 2003]
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G. Blood. 2003 Jan 1; 101(1):270-7. Epub 2002 Aug 29.
AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. [Nat Med. 2001]
AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG. Nat Med. 2001 Apr; 7(4):444-51.
Review Molecular basis of the t(8;21) translocation in acute myeloid leukaemia. [Semin Cancer Biol. 1993]
Review Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.
Ohki M. Semin Cancer Biol. 1993 Dec; 4(6):369-75.
Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21). [Cancer. 1995]
Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL, Chan V, Wong KF, Chan TK. Cancer. 1995 Feb 1; 75(3):821-5.
Review Epigenetic regulation of tumor suppressors in t(8:21)-containing AML. [Ann Hematol. 2004]
Review Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Yang G, Khalaf W, van de Locht L, Jansen JH, van der Reijden BA, Müller-Tidow C, Delwel HR, Serve H, Clapp DW, Hiebert SW. Ann Hematol. 2004 Jun; 83(6):329-30. Epub 2004 Mar 30.

See reviews... See all...

Cited by 27 PubMed Central articles

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia. [Cell Death Dis. 2013]
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.
Barbetti V, Tusa I, Cipolleschi MG, Rovida E, Dello Sbarba P. Cell Death Dis. 2013 Mar 14; 4:e536. Epub 2013 Mar 14.
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. [Epigenetics. 2013]
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V, Dello Sbarba P, Rovida E. Epigenetics. 2013 Feb; 8(2):210-9. Epub 2013 Jan 15.
AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. [Cancer Res. 2010]
AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
Dunne J, Gascoyne DM, Lister TA, Brady HJ, Heidenreich O, Young BD. Cancer Res. 2010 May 15; 70(10):3985-95. Epub 2010 May 11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Oncogene. 2001 Sep 10 ;20(40):5660-79.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

Source

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 27 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information